Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chemed Corporation stock logo
CHE
Chemed
$533.03
+0.1%
$467.11
$365.20
$551.68
$7.07B0.51167,486 shs221,552 shs
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$233.21
+0.1%
$207.36
$166.76
$240.13
$25.74B0.581.13 million shs872,503 shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$309.47
+0.1%
$274.71
$244.52
$316.11
$25.38B0.87795,351 shs1.09 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$577.11
$507.61
$373.00
$677.90
$16.11B1.15396,431 shs261,429 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chemed Corporation stock logo
CHE
Chemed
0.00%+4.46%+8.88%+26.42%+27.49%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.00%+2.26%+8.29%+21.15%+36.53%
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.00%+4.30%+7.95%+20.72%+18.42%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
0.00%-4.04%+3.50%+38.22%+36.40%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Chemed Corporation stock logo
CHE
Chemed
$533.03
+0.1%
$467.11
$365.20
$551.68
$7.07B0.51167,486 shs221,552 shs
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$233.21
+0.1%
$207.36
$166.76
$240.13
$25.74B0.581.13 million shs872,503 shs
Labcorp Holdings Inc. stock logo
LH
Labcorp
$309.47
+0.1%
$274.71
$244.52
$316.11
$25.38B0.87795,351 shs1.09 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$577.11
$507.61
$373.00
$677.90
$16.11B1.15396,431 shs261,429 shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Chemed Corporation stock logo
CHE
Chemed
0.00%+4.46%+8.88%+26.42%+27.49%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.00%+2.26%+8.29%+21.15%+36.53%
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.00%+4.30%+7.95%+20.72%+18.42%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
0.00%-4.04%+3.50%+38.22%+36.40%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Chemed Corporation stock logo
CHE
Chemed
2.17
Hold$530.75-0.43% Downside
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
2.46
Hold$235.310.90% Upside
Labcorp Holdings Inc. stock logo
LH
Labcorp
2.75
Moderate Buy$323.274.46% Upside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.15
Hold$584.181.23% Upside

Current Analyst Ratings Breakdown

Latest CHE, MEDP, DGX, and LH Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/31/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Boost Price TargetOverweight$308.00 ➝ $338.00
7/31/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Reiterated RatingHold$306.00
7/31/2026
Chemed Corporation stock logo
CHE
Chemed
Boost Price TargetOutperform$500.00 ➝ $590.00
7/31/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Set Price Target$352.00
7/31/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Boost Price TargetBuy$320.00 ➝ $350.00
7/30/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
Boost Price TargetEqual Weight$290.00 ➝ $320.00
7/30/2026
Chemed Corporation stock logo
CHE
Chemed
Boost Price TargetSector Perform$436.00 ➝ $548.00
7/29/2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Set Price Target$260.00
7/29/2026
Chemed Corporation stock logo
CHE
Chemed
Reiterated RatingNeutral
7/28/2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
Boost Price TargetNeutral$220.00 ➝ $250.00
7/24/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
UpgradeBuy (B-)Buy (B)
(Data available from 8/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Chemed Corporation stock logo
CHE
Chemed
$2.53B2.80$24.70 per share21.58$69.15 per share7.71
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$11.56B2.23$15.18 per share15.36$64.78 per share3.60
Labcorp Holdings Inc. stock logo
LH
Labcorp
$13.95B1.82$24.86 per share12.45$103.98 per share2.98
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.53B6.37$17.01 per share33.92$16.30 per share35.41
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Chemed Corporation stock logo
CHE
Chemed
$265.24M$19.9126.7720.942.0210.60%31.77%18.90%N/A
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$992M$9.4224.7619.522.159.18%16.01%7.27%10/20/2026 (Estimated)
Labcorp Holdings Inc. stock logo
LH
Labcorp
$876.50M$12.0925.6015.851.886.99%16.74%7.81%N/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$451.12M$17.0633.8330.102.5717.67%110.15%24.84%N/A

Latest CHE, MEDP, DGX, and LH Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2026Q2 2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
$4.78$4.99+$0.21$3.64$3.71 billion$3.73 billion
7/28/2026Q2 2026
Chemed Corporation stock logo
CHE
Chemed
$5.60$6.06+$0.46$5.13$665.04 million$673.25 million
7/23/2026Q2 2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$2.82$3.12+$0.30$2.84$2.97 billion$3.04 billion
7/22/2026Q2 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.98$4.25+$0.27$4.25$689.51 million$707.33 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Chemed Corporation stock logo
CHE
Chemed
$2.400.45%+10.76%12.05%16 Years
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
$3.441.48%+7.34%36.52%14 Years
Labcorp Holdings Inc. stock logo
LH
Labcorp
$2.880.93%N/A23.82%N/A
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A

Latest CHE, MEDP, DGX, and LH Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/9/2026
Labcorp Holdings Inc. stock logo
LH
Labcorp
quarterly$0.721.04%8/28/20268/28/20269/11/2026
5/19/2026
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
quarterly$0.861.65%7/8/20267/8/20267/22/2026
5/18/2026
Chemed Corporation stock logo
CHE
Chemed
quarterly$0.600.55%5/28/20265/28/20266/16/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Chemed Corporation stock logo
CHE
Chemed
0.17
0.91
0.89
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.72
1.59
1.46
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.69
1.80
1.53
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.73
0.73

Institutional Ownership

CompanyInstitutional Ownership
Chemed Corporation stock logo
CHE
Chemed
95.85%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
88.06%
Labcorp Holdings Inc. stock logo
LH
Labcorp
95.94%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%

Insider Ownership

CompanyInsider Ownership
Chemed Corporation stock logo
CHE
Chemed
3.33%
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
0.88%
Labcorp Holdings Inc. stock logo
LH
Labcorp
0.84%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Chemed Corporation stock logo
CHE
Chemed
15,81113.27 million12.83 millionOptionable
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
57,000110.37 million109.40 millionOptionable
Labcorp Holdings Inc. stock logo
LH
Labcorp
71,00082.00 million81.31 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
6,20027.91 million22.19 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Chemed stock logo

Chemed NYSE:CHE

$533.03 +0.78 (+0.15%)
Closing price 07/31/2026 03:59 PM Eastern
Extended Trading
$532.18 -0.85 (-0.16%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Quest Diagnostics stock logo

Quest Diagnostics NYSE:DGX

$233.21 +0.20 (+0.09%)
Closing price 07/31/2026 03:59 PM Eastern
Extended Trading
$233.06 -0.15 (-0.06%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Labcorp stock logo

Labcorp NYSE:LH

$309.47 +0.27 (+0.09%)
Closing price 07/31/2026 03:59 PM Eastern
Extended Trading
$309.53 +0.06 (+0.02%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Medpace stock logo

Medpace NASDAQ:MEDP

$577.11 0.00 (0.00%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$576.70 -0.41 (-0.07%)
As of 07/31/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.